Multiple myeloma trials in Russia

3 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Enrolling by invitation
  International Treatment-extension Study in Adult Participants With Multiple Myeloma and Who Have Derived Clinical Benefit From Isatuximab

  Where

  Kirov, Moscow

  Age

  18 years and over

  People

  70 worldwide

  Run by

  Sanofi

  See details and how to joinNCT05669989
• Phase 3Taking people
  A Study of the Efficacy and Safety of BCD-248 in Combination With Daratumumab in Patients With Relapsed or Refractory Multiple Myeloma (AMMADINA)

  Where

  Chelyabinsk, Irkutsk, Kazan', Krasnoyarsk, Moscow, Omsk, Saint Petersburg, Samara, Saratov, Smolensk, Sochi, Ufa

  Age

  18 years and over

  People

  390 worldwide

  Run by

  Biocad

  See details and how to joinNCT07742215
• Phase 2Taking people
  An Open-Label Clinical Study of the Efficacy and Safety of BCD-248 in Patients With Relapsed/Refractory Multiple Myeloma

  Where

  Kaliningrad, Kazan', Kirov, Krasnoyarsk, Moscow, Obninsk, Petrozavodsk, Saint Petersburg, Samara, Saratov, Smolensk, Sochi, Syktyvkar, Ufa, Yekaterinburg

  Age

  18 years and over

  People

  100

  Run by

  Biocad

  See details and how to joinNCT06668792